Danaher Corporation (DHR) has received waves of contrasting action from investors, with multiple entities investing, selling off, and contracting their positions in the company. For instance, Bradyco Inc., reaffirms confidence in the firm with fresh investment worth $299K. Similarly, Callan Family Office LLC, Victory Capital Management Inc., Welch & Forbes LLC, and a host of other companies, have all increased their stakes by acquiring more shares. On the flip side, some entities including M&T Bank Corp and others have decreased their stock holdings. There are significant share acquisitions by Bailard Inc. and others coupled by sell-offs by entities like Connable Office Inc. Amid these transactions, questions arise if DHR is the best manufacturing or cancer stock to buy now or if it is underperforming the S&P 500. Renowned investment advisor, Jim Cramer expressed disappointment in DHR's performance and restlessness about waiting for a better performance. This mixed bag of reactions comes against the backdrop of the company's stock plunge in 2025, amidst missed EPS estimates, and lawsuits on stock drops.
Danaher Corporation DHR News Analytics from Tue, 22 Oct 2024 07:00:00 GMT to Sat, 08 Mar 2025 12:14:25 GMT -
Rating -4
- Innovation 1
- Information 6
- Rumor -2
